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OBJECTIVE: Several studies have presented conﬂicting
reports concerning the relationship between paternal
organic solvent exposure and major malformations
(MMs). We conducted a meta-analysis to evaluate and
quantify that risk. METHODS: A literature search was
performed on Medline, Toxline, and Embase. We
searched for all original comparative research studies,
published from 1966 to the present (2002), and that
examined the association between paternal pre- and 
periconceptional exposure to organic solvents and sub-
sequent major fetal malformations. Speciﬁc outcomes
included neural tube defects, spina biﬁda, anencephaly,
and clubfoot. Two independent reviewers identiﬁed and
extracted the data; disagreements were resolved by con-
sensus. The Mantel-Haenszel method was used to calcu-
late summary odds ratios (ORs) with 95% conﬁdence
intervals (CI); we also used weighted average lnOR when
data allowed. Homogeneity of effects was assessed using
chi-square and a funnel plot was used to examine publi-
cation bias. RESULTS: Forty-four studies were identiﬁed;
36 were excluded (13 examined inappropriate exposures,
9 had inappropriate outcomes, 9 were reviews, 4 had no
extractable data, 1 was a duplicate). Eight studies pro-
vided useable data, but the exposure assessment varied
considerably. Some studies used only occupational codes,
while others conducted telephone interviews to insure
actual exposure. No studies displayed heterogeneity 
(P > 0.05) or publication bias. Overall results were sig-
niﬁcant (ORs = 1.84, CI 95%: 1.42–2.39, N = 116,811).
For overall neural tube defects (NTDs, N = 116,690),
ORs = 1.93 (CI 95%: 1.49–2.59). For case control studies
(N = 17,414), ORs = 1.93 (CI 95%: 1.34–2.78). For
cohort studies (N = 99,276), ORs = 1.91 (CI 95%:
1.21–3.03). When all available data (n = 117,561) were
combined, ORs = 1.92 (CI 95%: 1.51–2.44). For spina
biﬁda (N = 24,333), ORs = 1.48 (CI 95%: 1.00–2.20),
but when all available data (N = 25,204) were combined,
ORs = 1.56 (CI 95%: 1.10–2.22) and signiﬁcance
returned. For anencephaly (N = 109.123), ORs = 2.36 (CI
95%: 1.58–3.51). For case control studies (N = 9,847),
ORs = 2.84 (CI 95%: 1.50–5.39), and for cohort studies
(N = 99,276), ORs = 1.93 (CI 95%: 1.15–3.23). CON-
CLUSION: The risk for major malformation is signiﬁ-
cantly increased by the paternal occupational exposure to
organic solvents.
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OBJECTIVE: It has been well-documented that the risk
of neural tube defects is reduced with the use of folic acid
preconceptionally, yet no nationally representative study
has presented the use of vitamins in women of child-
bearing potential stratiﬁed by race and other important
confounders. The current study was designed to deter-
mine the patterns of vitamin use among all women of
childbearing potential and pregnant women (15 to 45
years of age), with a focus on examining racial disparity
in the access to vitamins. METHODS: Analysis of 1997
Medical Expenditure Panel Survey (MEPS) data, a nation-
ally representative survey of the US population. Partici-
pants included all women respondents 15 to 45 years of
age. The main outcome measures were the rate of vitamin
use in all women and in pregnant women. RESULTS: In
1997, more than half of pregnant women 15 to 45 years
of age reported vitamin use (51.6%) while a mere 9.0%
of all women 15 to 45 years of age reported vitamin use.
No racial disparity was seen in the use of vitamins by all
women or by pregnant women 15 to 45 years of age.
Pregnancy status was the single signiﬁcant variable that
increased the use of vitamins by all women (OR = 61.77,
95% CI 22.84, 167.06). CONCLUSIONS: Given the link
between folic acid and a reduction of the risk of neural
tube defects, it is surprising that so few women in the
MEPS data reported taking vitamins (particularly folic
acid) before pregnancy. Additional interventions are 
necessary so that more women of childbearing potential
are aware of the beneﬁts of folic acid.
